We are live on ! Find out more
BCP

Berkeley Capital Partners Portfolio holdings

AUM $431M
1-Year Est. Return 17.43%
This Fund
S&P 500
This Quarter Est. Return
+1.61%
1 Year Est. Return
+17.43%
3 Year Est. Return
+49.31%
5 Year Est. Return
+56.96%
10 Year Est. Return
+157.09%
AUM
$332M
AUM Growth
+$4.11M
Cap. Flow
+$632K
Cap. Flow %
0.19%
Top 10 Hldgs %
51.87%
Holding
168
New
3
Increased
93
Reduced
61
Closed
6

Top Buys

Rank Stock Value
1
MMM icon
3M
MMM
+$1.12M
2
BMY icon
Bristol-Myers Squibb
BMY
+$386K
3
BAX icon
Baxter International
BAX
+$306K
4
IBM icon
IBM
IBM
+$278K
5
AAPL icon
Apple
AAPL
+$269K

Sector Composition

Rank Sector Weight
1 Technology 6.81%
2 Healthcare 4.24%
3 Consumer Staples 4.17%
4 Financials 3.81%
5 Consumer Discretionary 2.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KO icon
51
Coca-Cola
KO
$377B
$1.29M 0.39%
20,262
+310
+2% +$19.2K
MO icon
52
Altria Group
MO
$114B
$1.27M 0.38%
27,943
+1,142
+4% +$50.7K
ABBV icon
53
AbbVie
ABBV
$443B
$1.24M 0.37%
7,204
-18
-0.2% -$2.98K
VB icon
54
Vanguard Morningstar Small-Cap ETF
VB
$79.5B
$1.2M 0.36%
5,503
+619
+13% +$136K
BCE icon
55
BCE
BCE
$20.2B
$1.18M 0.35%
36,339
+1,966
+6% +$65.5K
IWF icon
56
iShares Russell 1000 Growth ETF
IWF
$121B
$1.17M 0.35%
12,864
-220
-2% -$18.8K
MMM icon
57
3M
MMM
$90.9B
$1.17M 0.35%
+11,452
New +$1.12M
UNH icon
58
UnitedHealth
UNH
$376B
$1.11M 0.33%
2,174
+114
+6% +$55.9K
BAX icon
59
Baxter International
BAX
$13.5B
$1.1M 0.33%
32,960
+8,291
+34% +$306K
LLY icon
60
Eli Lilly
LLY
$1.02T
$1.09M 0.33%
1,209
+132
+12% +$106K
GOOG icon
61
Alphabet (Google) Class C
GOOG
$4.36T
$1.09M 0.33%
5,951
+53
+0.9% +$9.02K
V icon
62
Visa
V
$684B
$1.07M 0.32%
4,091
+94
+2% +$25.8K
SO icon
63
Southern Company
SO
$109B
$1.06M 0.32%
13,669
-127
-0.9% -$9.62K
GD icon
64
General Dynamics
GD
$104B
$1.06M 0.32%
3,649
+29
+0.8% +$8.49K
K
65
DELISTED
Kellanova
K
$1.06M 0.32%
18,338
-53
-0.3% -$3.13K
VCR icon
66
Vanguard Consumer Discretionary ETF
VCR
$6.15B
$1.06M 0.32%
3,383
+37
+1% +$11.3K
VTV icon
67
Vanguard Morningstar Value ETF
VTV
$188B
$1.03M 0.31%
6,451
+783
+14% +$125K
AFL icon
68
Aflac
AFL
$64.9B
$1.03M 0.31%
11,548
+48
+0.4% +$4.13K
JCI icon
69
Johnson Controls International
JCI
$88.8B
$1.03M 0.31%
15,447
-268
-2% -$18K
JNJ icon
70
Johnson & Johnson
JNJ
$618B
$961K 0.29%
6,574
+334
+5% +$49.7K
VV icon
71
Vanguard Morningstar Large-Cap ETF
VV
$52.4B
$955K 0.29%
3,825
-30
-0.8% -$7.21K
TSLA icon
72
Tesla
TSLA
$1.23T
$949K 0.29%
4,795
+69
+1% +$12.1K
META icon
73
Meta Platforms (Facebook)
META
$1.42T
$937K 0.28%
1,859
+195
+12% +$94.8K
IGLB icon
74
iShares 10+ Year Investment Grade Corporate Bond ETF
IGLB
$2.62B
$929K 0.28%
18,567
-298
-2% -$14.9K
PANW icon
75
Palo Alto Networks
PANW
$270B
$927K 0.28%
5,470
+446
+9% +$66.7K

Similar funds

Berkeley Capital Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Berkeley Capital Partners held 168 positions worth $332M, up 1.3% from $328M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Berkeley Capital Partners's Q2 2024 filing shows 3 new, 93 increased, 61 reduced and 6 closed positions. Its largest new stake was 3M: 11,452 shares worth $1.17M. The largest sale was Freshpet, an estimated $1.25M.

By sector, the portfolio is most concentrated in Technology at 6.8% of assets, up from 5.8% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Berkeley Capital Partners's largest Q2 2024 buy was 3M: 11,452 shares worth $1.17M.
  • Berkeley Capital Partners added most to Bristol-Myers Squibb in Q2 2024, an estimated $386K increase.
  • Berkeley Capital Partners's biggest Q2 2024 reduction was RTX Corp, cutting an estimated $1.13M.
  • Berkeley Capital Partners fully exited Freshpet in Q2 2024, selling an estimated $1.25M.
  • Berkeley Capital Partners's ten largest holdings make up 52% of its $332M portfolio in Q2 2024.
  • Berkeley Capital Partners opened 3 new positions and closed 6 in Q2 2024.
  • Berkeley Capital Partners's portfolio value rose 1.3% quarter-over-quarter to $332M.

Based on Berkeley Capital Partners's 13F filing for Q2 2024, filed 14 Aug 2024.